Session 77: Brain Metastases and fundamental research
Tracks
Hall 3
| Saturday, October 3, 2026 |
| 8:00 AM - 9:30 AM |
Details
Kostas Gousias, Rebeca Perez
Speakers & Chairs
Prof. Maximilian I. Ruge
Vice Chairman
Uniklinik Köln
Pre- vs postoperative radiation therapy for brain metastasis
8:00 AM - 8:10 AM
Prof Jagoš Golubović
Consultant
Clinical Centre of Vojvodina, University of Novi Sad, Faculty of Medicine
Contemporary framework in collaborative brain metastasis treatment
8:10 AM - 8:20 AM
Prof. Einar O. Vik-mo
Head Of Surgical Neuro-oncology
Oslo University Hospital
Repeat surgery for brain mets
8:20 AM - 8:30 AM
Dr Tunc Faik Ersoy
Consultant
Universität Bielefeld, Medizinische Fakultät und Universitätsklinikum OWL, Evangelisches Klinikum Bethel
Influence of Molecular Subtypes of Breast Cancer on Surgical Outcomes of Patients undergoing Brain Metastases (BM) Surgery
Dr Lina-Elisabeth Qasem
Doctor
Goethe University Frankfurt
The HiResMet Trial: Targeting the Perimetastatic Niche – Cellular-guided R0-Resection in Brain Metastases
Dr Khalid Sarhan
Second Year Intern
Department Of Neurosurgery, Mansoura University Hospitals
Primary Tumor Origin Drives Survival After Stereotactic Radiosurgery for Gynecologic Brain Metastases: An Individual Patient Data Meta-Analysis
Dr. Tommaso Araceli
Resident
University Hospital Regensburg, Department of Neurosurgery
TTF1-negative lung adenocarcinoma brain metastases undergo transcriptional reprogramming with increased invasiveness, tumor aggressivity, and shorter survival
Dr Lukasz Antkowiak
Postdoctoral Researcher, PGY-3 Neurosurgery Resident
Medical University of Silesia in Katowice
SOX2, OCT4, and NANOG knockdown activate cell cycle checkpoints, promote invasion, and induce apoptosis in glioblastoma cells.
Dr. Malte Mohme
Senior Attending
Department of Neurosurgery, University Medical Center Hamburg-Eppendorf
Nanobody-Decorated AAVs Target Purinergic Checkpoints in the Glioblastoma Microenvironment
Ms Louisa Beatrice Gulden
Medical Student
University Medicine Halle
Concomitant Effects Of Tumor Treating Fields (TTFields) And Nimodipine On Glioblastoma Cells
Discussion
Discussion
9:25 AM - 9:30 AM
Prof. Konstantinos Gousias
Director
Athens Medical Center
Chair
Dr. Rebeca Perez Alfayate
Neurosurgeon
Hospital Clinico San Carlos
Chair
